AUTERI, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 385
EU - Europa 206
AS - Asia 85
SA - Sud America 11
AF - Africa 6
OC - Oceania 2
Totale 695
Nazione #
US - Stati Uniti d'America 370
IT - Italia 58
DE - Germania 33
IE - Irlanda 29
FR - Francia 28
CN - Cina 24
JP - Giappone 24
IN - India 17
CA - Canada 14
GB - Regno Unito 13
BG - Bulgaria 10
CO - Colombia 8
CH - Svizzera 5
PL - Polonia 5
SE - Svezia 5
AT - Austria 4
NL - Olanda 4
BR - Brasile 3
ES - Italia 3
MA - Marocco 3
MY - Malesia 3
TR - Turchia 3
TW - Taiwan 3
AU - Australia 2
DK - Danimarca 2
HK - Hong Kong 2
ID - Indonesia 2
JO - Giordania 2
LV - Lettonia 2
UA - Ucraina 2
CZ - Repubblica Ceca 1
EG - Egitto 1
IL - Israele 1
KG - Kirghizistan 1
LT - Lituania 1
MX - Messico 1
NG - Nigeria 1
PK - Pakistan 1
QA - Qatar 1
RU - Federazione Russa 1
SG - Singapore 1
ZA - Sudafrica 1
Totale 695
Città #
Ashburn 38
Dublin 29
Houston 23
Santa Cruz 22
Bologna 17
Ann Arbor 15
Fairfield 14
New York 12
Seattle 11
Bremen 10
Buffalo 10
Sofia 10
Bogotá 8
Chicago 8
Mountain View 8
Paris 8
Boardman 6
Cambridge 6
Los Angeles 6
Milan 6
Beijing 5
Chennai 5
Waukegan 5
Apex 4
Southend 4
Stockholm 4
Arlington 3
Atlanta 3
Bengaluru 3
Brooklyn 3
Columbus 3
Dallas 3
Fleming Island 3
Frankfurt am Main 3
Germantown 3
Hangzhou 3
Limidi 3
Marcus Hook 3
Marseille 3
San Diego 3
Sapporo 3
Toronto 3
Treviso 3
Woodbridge 3
Amsterdam 2
Bari 2
Boston 2
Brandon 2
Brockville 2
Cedar Knolls 2
Chagrin Falls 2
Chongqing 2
Delhi 2
Denver 2
Esslingen am Neckar 2
Ferrara 2
Florence 2
Forlì 2
Fremont 2
Gurgaon 2
Hanover 2
Herndon 2
Jakarta 2
Kajang 2
Kennett Square 2
Lake Forest 2
Las Vegas 2
Madison 2
Milpitas 2
Motomiya 2
Nardò 2
Nilufer 2
Ottawa 2
Ozarow Mazowiecki 2
Philadelphia 2
Polska 2
Portland 2
Pune 2
Reston 2
Riga 2
Sagamihara 2
San Francisco 2
Shizuoka 2
Taipei 2
Trenton 2
Vienna 2
Washington 2
Aachen 1
Augusta 1
Baltimore 1
Bangalore 1
Birmingham 1
Brescia 1
Brisbane 1
Burlington 1
Böblingen 1
Capo D'orlando 1
Casablanca 1
Chantilly 1
Clearwater 1
Totale 447
Nome #
null, file e1dcb336-5e2c-7715-e053-1705fe0a6cc9 201
Differences in presenting features, outcome and prognostic models in patients with primary myelofibrosis and post-polycythemia vera and/or post-essential thrombocythemia myelofibrosis treated with ruxolitinib. New perspective of the MYSEC-PM in a large multicenter study⁎, file e1dcb336-e7c0-7715-e053-1705fe0a6cc9 134
Disease-specific derangement of circulating endocannabinoids and n-acylethanolamines in myeloproliferative neoplasms, file e1dcb335-d839-7715-e053-1705fe0a6cc9 70
Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis, file e1dcb337-834e-7715-e053-1705fe0a6cc9 69
Mobilized Peripheral Blood versus Cord Blood: Insight into the distinct role of proinflammatory cytokines on survival, clonogenic ability, and migration of CD34+ cells, file e1dcb332-6313-7715-e053-1705fe0a6cc9 50
A specific host/microbial signature of plasma-derived extracellular vesicles is associated to thrombosis and marrow fibrosis in polycythemia vera, file e1dcb338-acec-7715-e053-1705fe0a6cc9 39
An Abnormal Host/Microbiomes Signature of Plasma-Derived Extracellular Vesicles Is Associated to Polycythemia Vera, file e1dcb338-ff8c-7715-e053-1705fe0a6cc9 35
Risk factors for progression to blast phase and outcome in 589 patients with myelofibrosis treated with ruxolitinib: Real-world data, file e1dcb337-123a-7715-e053-1705fe0a6cc9 24
Distinct profile of CD34+ cells and plasma-derived extracellular vesicles from triple-negative patients with Myelofibrosis reveals potential markers of aggressive disease, file e1dcb338-615c-7715-e053-1705fe0a6cc9 15
Immune thrombotic thrombocytopenic purpura: Personalized therapy using ADAMTS-13 activity and autoantibodies, file b1ef4e82-477e-4642-aab4-f2235bdda485 14
Distinct profile of CD34+ cells and plasma-derived extracellular vesicles from triple-negative patients with Myelofibrosis reveals potential markers of aggressive disease, file 4c76a4f7-c45f-4747-a6b2-bde12b1443f5 12
The diagnostic role of next generation sequencing in uncovering isolated splenomegaly: A case report, file e1dcb339-2d0c-7715-e053-1705fe0a6cc9 11
The role of circulating monocytes and JAK inhibition in the infectious-driven inflammatory response of myelofibrosis, file a5e29f47-3c96-4bb3-a305-7eecfc9623be 10
Peripheral blasts are associated with responses to ruxolitinib and outcomes in patients with chronic-phase myelofibrosis, file f416e33c-6433-434e-8427-dbb776c3a799 6
An Abnormal Host/Microbiomes Signature of Plasma-Derived Extracellular Vesicles Is Associated to Polycythemia Vera, file 5e9c457d-6ff2-48a0-a0fe-49cdcbee910f 4
The role of circulating monocytes and JAK inhibition in the infectious-driven inflammatory response of myelofibrosis, file 3605d2d4-cde3-42d9-946b-36ebf010ba94 3
TOWARD THE IDENTIFICATION OF A MICRORNA-BASED SIGNATURE OF CIRCULATING MICROPARTICLES FROM TRIPLE NEGATIVE AND JAK2(V617F) MUTATED PATIENTS WITH MYELOFIBROSIS, file e1dcb332-6317-7715-e053-1705fe0a6cc9 3
A specific host/microbial signature of plasma-derived extracellular vesicles is associated to thrombosis and marrow fibrosis in polycythemia vera, file e1dcb339-fa3a-7715-e053-1705fe0a6cc9 3
Longer-term response to SARS-CoV-2 vaccine in MPN patients: Role of ruxolitinib and disease severity, file 36814fc8-b12d-454d-a220-3bce00ba2b80 2
Management of elderly patients with immune thrombocytopenia: Real-world evidence from 451 patients older than 60 years., file e1dcb334-6b8c-7715-e053-1705fe0a6cc9 1
Impact of 2016 WHO diagnosis of early and overt primary myelofibrosis on presentation and outcome of 232 patients treated with ruxolitinib., file e1dcb334-7040-7715-e053-1705fe0a6cc9 1
Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis, file e1dcb334-7501-7715-e053-1705fe0a6cc9 1
Totale 708
Categoria #
all - tutte 1.838
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.838


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 1 0 0 0
2019/20206 0 0 0 0 0 0 0 0 2 1 2 1
2020/202183 4 2 5 2 2 1 2 8 12 16 9 20
2021/2022194 11 11 11 38 26 4 10 14 12 12 33 12
2022/2023250 8 8 26 41 18 19 11 10 40 22 31 16
2023/2024173 10 20 8 33 26 29 27 20 0 0 0 0
Totale 708